Solid Biosciences Inc. (SLDB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$25.58M2017: -$54.86M2018: -$75.69M2019: -$119.32M2020: -$88.41M2021: -$72.25M2022: -$106.45M2023: -$104.25M2024: -$129.73M2025: -$179.21M-$179.21M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$179.21M-38.1%
2024-$129.73M-24.4%
2023-$104.25M+2.1%
2022-$106.45M-47.3%
2021-$72.25M+18.3%
2020-$88.41M+25.9%
2019-$119.32M-57.6%
2018-$75.69M-38.0%
2017-$54.86M-114.5%
2016-$25.58M